UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization

Pharmaceutical research, 2024-08, Vol.41 (8), p.1703-1723

2024

Volltextzugriff (PDF)

Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization

Pharmaceutical research, 2024-09, Vol.41 (9), p.1903-1903

2024

Volltextzugriff (PDF)

Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation

Pharmaceutical research, 2022-12, Vol.39 (12), p.3317-3330

2022

Volltextzugriff (PDF)

Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part II: In vivo Efficacy Testing in a Rabbit Surfactant Washout Model

Pharmaceutical research, 2024-09, Vol.41 (9), p.1827-1842

2024

Volltextzugriff (PDF)

Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates

Pharmaceutical research, 2021-09, Vol.38 (9), p.1615-1632

2021

Volltextzugriff (PDF)

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization

Pharmaceutics, 2021-08, Vol.13 (8), p.1254

2021

Volltextzugriff (PDF)

Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies

Pharmaceutics, 2019-10, Vol.11 (10), p.502

2019

Volltextzugriff (PDF)

High dose dry powder inhalers to overcome the challenges of tuberculosis treatment

International journal of pharmaceutics, 2018-10, Vol.550 (1-2), p.398-417

2018

Volltextzugriff (PDF)

Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations

International journal of pharmaceutics, 2023-08, Vol.643, p.123199-123199, Article 123199

2023

Volltextzugriff (PDF)

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

International journal of pharmaceutics, 2019-10, Vol.570, p.118689, Article 118689

2019

Volltextzugriff (PDF)

Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels

Journal of aerosol science, 2024-01, Vol.175, p.106262, Article 106262

2024

Volltextzugriff (PDF)

Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis

International journal of pharmaceutics, 2017-08, Vol.528 (1-2), p.107-117

2017

Volltextzugriff (PDF)

Effects of different mesh nebulizer sources on the dispersion of powder formulations produced with a new small-particle spray dryer

International journal of pharmaceutics, 2023-07, Vol.642, p.123138-123138, Article 123138

2023

Volltextzugriff (PDF)

Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections

International journal of pharmaceutics, 2018-04, Vol.541 (1-2), p.26-36

2018

Volltextzugriff (PDF)

Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug

International journal of pharmaceutics, 2018-05, Vol.543 (1-2), p.318-327

2018

Volltextzugriff (PDF)

In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants

Journal of aerosol medicine and pulmonary drug delivery, 2022-08, Vol.35 (4), p.196-211

2022

Volltextzugriff (PDF)

Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome

AAPS PharmSciTech, 2021-04, Vol.22 (4), p.136-136, Article 136

2021

Volltextzugriff (PDF)

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis

Drug development and industrial pharmacy, 2019-08, Vol.45 (8), p.1321-1331

2019

Volltextzugriff (PDF)

Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations

AAPS PharmSciTech, 2021-04, Vol.22 (4), p.135-135, Article 135

2021

Volltextzugriff (PDF)

Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model

AAPS PharmSciTech, 2022-04, Vol.23 (5), p.114-114, Article 114

2022

Volltextzugriff (PDF)

In Vitro Evaluation of Nebulized Pharmaceutical Aerosol Delivery to the Lungs Using a New Heated Dryer System (HDS)

AAPS PharmSciTech, 2022-11, Vol.24 (1), p.10-10, Article 10

2022

Volltextzugriff (PDF)

Development and validation of a RP-HPLC method for simultaneous quantification of bedaquiline (TMC207), moxifloxacin and pyrazinamide in a pharmaceutical powder formulation for inhalation

Journal of liquid chromatography & related technologies, 2018-05, Vol.41 (8), p.415-421

2018

Volltextzugriff (PDF)

The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin

Drug development and industrial pharmacy, 2019-07, Vol.45 (7), p.1205-1213

2019

Volltextzugriff (PDF)

Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis

Journal of pharmaceutical and biomedical analysis, 2017-02, Vol.135, p.133-139

2017

Volltextzugriff (PDF)

Editorial: Strategies to overcome the barriers to effective inhaled treatments

Frontiers in Drug Delivery, 2023-07, Vol.3

2023

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(65)
Berichte
(1)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization

Correction: Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part I: In Vitro Testing and Characterization

Development of a High-Dose Infant Air-Jet Dry Powder Inhaler (DPI) with Passive Cyclic Loading of the Formulation

Development of a New Dry Powder Aerosol Synthetic Lung Surfactant Product for Neonatal Respiratory Distress Syndrome (RDS) – Part II: In vivo Efficacy Testing in a Rabbit Surfactant Washout Model

Advancement of the Infant Air-Jet Dry Powder Inhaler (DPI): Evaluation of Different Positive-Pressure Air Sources and Flow Rates

Roflumilast Powders for Chronic Obstructive Pulmonary Disease: Formulation Design and the Influence of Device, Inhalation Flow Rate, and Storage Relative Humidity on Aerosolization

Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety Studies

High dose dry powder inhalers to overcome the challenges of tuberculosis treatment

Advancement of a high-dose infant air-jet dry powder inhaler (DPI) with passive cyclic loading: Performance tuning for different formulations

Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis

Development of an effective two-equation turbulence modeling approach for simulating aerosol deposition across a range of turbulence levels

Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis

Effects of different mesh nebulizer sources on the dispersion of powder formulations produced with a new small-particle spray dryer

Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infections

Manipulation of spray-drying conditions to develop dry powder particles with surfaces enriched in hydrophobic material to achieve high aerosolization of a hygroscopic drug

In Vitro Analysis of Nasal Interface Options for High-Efficiency Aerosol Administration to Preterm Infants

Development and Characterization of Excipient Enhanced Growth (EEG) Surfactant Powder Formulations for Treating Neonatal Respiratory Distress Syndrome

Carrier-free combination dry powder inhaler formulation of ethionamide and moxifloxacin for treating drug-resistant tuberculosis

Performance of Low Air Volume Dry Powder Inhalers (LV-DPI) when Aerosolizing Excipient Enhanced Growth (EEG) Surfactant Powder Formulations

Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model

In Vitro Evaluation of Nebulized Pharmaceutical Aerosol Delivery to the Lungs Using a New Heated Dryer System (HDS)

Development and validation of a RP-HPLC method for simultaneous quantification of bedaquiline (TMC207), moxifloxacin and pyrazinamide in a pharmaceutical powder formulation for inhalation

The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin

Simultaneous HPLC assay for pretomanid (PA-824), moxifloxacin and pyrazinamide in an inhaler formulation for drug-resistant tuberculosis

Editorial: Strategies to overcome the barriers to effective inhaled treatments

Suchergebnisse filtern